Han Cui
Changle West Road 169
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
Journal: Journal of nanobiotechnology
Published: October 09, 2018
Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: September 25, 2018
Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: August 12, 2018
Charge Reversible and Mitochondria/Nucleus Dual Target Lipid Hybrid Nanoparticles To Enhance Antitumor Activity of Doxorubicin.
Journal: Molecular pharmaceutics
Published: February 13, 2018
Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: January 17, 2018
The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 28, 2017
Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
Journal: Molecular pharmaceutics
Published: February 02, 2017
Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery.
Journal: Oncotarget
Published: October 31, 2016
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance.
Journal: Scientific reports
Published: June 01, 2016
Synthesis of doxorubicin α-linolenic acid conjugate and evaluation of its antitumor activity.
Journal: Molecular pharmaceutics
Published: April 12, 2014
Last Updated: 09/26/2026